Pharmacokinetic/Pharmacodynamic Modeling of Spiramycin against <i>Mycoplasma synoviae</i> in Chickens

Pharmacokinetic/Pharmacodynamic Modeling of Spiramycin against <i>Mycoplasma synoviae</i> in Chickens

This research aimed to assess the pharmacokinetics/pharmacodynamics (PK/PD) and tissue residues of spiramycin in chickens. The PK of spiramycin were determined in 12 chickens using a parallel study design in which each group of chickens (<i>n</i> = 6) received a single dose of spiramycin...

Full description

Bibliographic Details
Main Authors:	Sara T. Elazab, Nahla S. Elshater, Yousreya H. Hashem, Nayera M. Al-Atfeehy, Eon-Bee Lee, Seung-Chun Park, Walter H. Hsu
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	Pathogens
Subjects:	spiramycin HPLC pharmacokinetics withdrawal time pharmacodynamics
Online Access:	https://www.mdpi.com/2076-0817/10/10/1238

Similar Items

Effect of nitazoxanide and spiramycin metronidazole combination in acute experimental toxoplasmosis
by: Amal FarahatAllam, et al.
Published: (2020-04-01)

Spiramycin-associated Acute Pancreatitis: Cause or Coincidence?
by: Alpaslan Tanoglu, et al.
Published: (2015-06-01)

Comparative Study of the clinical effects of Levofloxacin and Spiramycin on induced colibacellosis in chicken
by: Shatha mousa mlaghee Al Safi, et al.
Published: (2017-12-01)

Comparative study of residues of Levofloxacin and Spiramycin in normal and infected tissues of chicken by HPLC
by: Shatha Mousa Mlaghee Al safi, et al.
Published: (2017-12-01)

Physicochemical Properties and In Vitro Dissolution of Spiramycin Microparticles Using the Homogenate-Antisolvent Precipitation Process
by: Xiaonan Zhang, et al.
Published: (2016-12-01)

Essai de traitement de la dermatophilose bovine à Madagascar par injections de spiramycine
by: A. Ranaivoson, et al.
Published: (1984-03-01)

Spiramycin Disarms <i>Pseudomonas aeruginosa</i> without Inhibiting Growth
by: Matteo Calcagnile, et al.
Published: (2023-03-01)

Effects of Lactobacilli acidophilus and/or spiramycin as an adjunct in toxoplasmosis infection challenged with diabetes
by: Enas A. El Saftawy, et al.
Published: (2023-09-01)

The prevalence of genotypes that determine resistance to macrolides, lincosamides, and streptogramins B compared with spiramycin susceptibility among erythromycin-resistant Staphylococcus epidermidis
by: Marek Juda, et al.
Published: (2016-03-01)

Spiramycin: The past and future of an antibiotic with pleiotropic effects in the therapy of community-acquired infections
by: O. I. Butranova, et al.
Published: (2024-11-01)

The Renaissance of Spiramycin in Clinical Practice
by: S. V. Yakovlev, et al.
Published: (2023-12-01)

Development and Characterization of SBA-15 Imprinted Polymers for Spiramycin Analysis
by: Lorena González-Gómez, et al.
Published: (2024-08-01)

EFFECT OF THREE ANTIBIOTICS ON BYPERIMENTAL INFECTION OF BROILERS WITH MYCOPLASMA GALLISEPTICUM
by: AH. Abed, et al.
Published: (2024-05-01)

Pharmacokinetic/pharmacodynamic integration of amphenmulin: a novel pleuromutilin derivative against Mycoplasma gallisepticum
by: Wenxiang Wang, et al.
Published: (2024-02-01)

Pharmacokinetic and Pharmacodynamic integration of tilmicosin against Mycoplasma gallisepticum in the target infection site in chickens
by: Nan Zhang, et al.
Published: (2022-09-01)

Anti-Inflammatory Effects of Spiramycin in LPS-Activated RAW 264.7 Macrophages
by: Jin-Kyu Kang, et al.
Published: (2022-05-01)

Pharmacokinetic and Pharmacodynamic Integration and Resistance Analysis of Tilmicosin Against Mycoplasma gallisepticum in an In Vitro Dynamic Model
by: Zilong Huang, et al.
Published: (2019-06-01)

Pharmacodynamics and pharmacokinetics of snake antivenom
by: Bhagya Nikapitiya, et al.
Published: (2018-06-01)

Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Integration of Enrofloxacin Following Single Oral Administration of Different Doses in Brown Trout (<i>Salmo trutta</i>)
by: Kamil Uney, et al.
Published: (2021-10-01)

Ivermectin: Difficulties in resolving pharmacokinetic and pharmacodynamic relationships in onchocerciasis
by: E N Shu, et al.
Published: (2004-01-01)

Pharmacodynamics and pharmacokinetics of nalbuphine in xylazine‑sedated horses
by: Amal Hammad, et al.
Published: (2023-05-01)

Key considerations based on pharmacokinetic/pharmacodynamic in the design of antibody-drug conjugates
by: Yangyang Gao, et al.
Published: (2025-01-01)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
by: Hirsh Elhence, et al.
Published: (2022-12-01)

Study on the mechanisms and Pharmacodynamic substances of Lian-Gui-Ning-Xin-Tang on Arrhythmia Therapy based on Pharmacodynamic–Pharmacokinetic associations
by: Liang Jiayu, et al.
Published: (2024-08-01)

Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated Patients
by: Alexandre Le Marouille, et al.
Published: (2021-10-01)

Pulmonary Pharmacokinetic and Pharmacodynamic Evaluation of Ampicillin/Sulbactam Regimens for Pneumonia Caused by Various Bacteria, including <i>Acinetobacter baumannii</i>
by: Tetsushu Onita, et al.
Published: (2023-02-01)

A Pharmacodynamic Study of Aminoglycosides against Pathogenic <i>E. coli</i> through Monte Carlo Simulation
by: Eon-Bee Lee, et al.
Published: (2023-12-01)

Population Pharmacokinetic–Pharmacodynamic Analysis of a Reserpine-Induced Myalgia Model in Rats
by: Gloria M. Alfosea-Cuadrado, et al.
Published: (2024-08-01)

Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation
by: Maria Kipourou, et al.
Published: (2023-02-01)

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
by: Mercè Brunet, et al.
Published: (2022-08-01)

Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
by: Raghunandan Reddy Kura, et al.
Published: (2018-05-01)

Effects of Carbamazepine and Phenytoin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban
by: Lien Thi Ngo, et al.
Published: (2020-10-01)

In vitro pharmacodynamics of nemonoxacin and other antimicrobial agents against Mycoplasma pneumoniae
by: Na Wang, et al.
Published: (2023-12-01)

The Pharmacokinetics and Pharmacodynamics of Iron Preparations
by: Susanna Burckhardt, et al.
Published: (2011-01-01)

Pharmacokinetic and Pharmacodynamic Properties of Rosmarinic Acid in Rat Cholestatic Liver Injury
by: Jianbin Min, et al.
Published: (2018-09-01)

Determination of the Pharmacokinetics and Pharmacodynamics of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol in a Cross-Over Cynomolgus Macaque Model of <i>Mycobacterium tuberculosis</i> Infection
by: Laura Sibley, et al.
Published: (2022-11-01)

Pharmacokinetic/pharmacodynamic comparison between generic and brand-name levofloxacin based on Monte Carlo simulation
by: Pan Ma, et al.
Published: (2023-06-01)

Pharmacokinetic–Pharmacodynamic Correlation Analysis of <i>Rhodiola crenulata</i> in Rats with Myocardial Ischemia
by: Zhixin Jia, et al.
Published: (2024-05-01)

The pharmacokinetics and pharmacodynamics of fentanyl administered via transdermal patch in horses
by: Rachel A. Reed, et al.
Published: (2024-03-01)

Cinnamon modulates the pharmacodynamic & pharmacokinetic of amlodipine in hypertensive rats
by: Ibrahim Abdelsalam Abdelrahman, et al.
Published: (2023-09-01)